MICU2
Basic information
Region (hg38): 13:21492691-21604181
Previous symbols: [ "EFHA1" ]
Links
Phenotypes
GenCC
Source:
- mitochondrial disease (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MICU2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 33 | 38 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 7 | 0 |
Variants in MICU2
This is a list of pathogenic ClinVar variants found in the MICU2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-21493272-G-C | not specified | Uncertain significance (Oct 12, 2021) | ||
13-21493274-T-A | not specified | Uncertain significance (Aug 04, 2023) | ||
13-21493304-T-G | not specified | Uncertain significance (Sep 16, 2021) | ||
13-21493342-A-C | not specified | Likely benign (Jun 11, 2021) | ||
13-21495232-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
13-21495255-G-C | not specified | Uncertain significance (Aug 27, 2024) | ||
13-21495268-T-G | not specified | Uncertain significance (Oct 26, 2024) | ||
13-21496121-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
13-21502942-T-A | MICU2-related disorder | Likely benign (Dec 31, 2019) | ||
13-21502943-T-A | MICU2-related disorder | Likely benign (Dec 31, 2019) | ||
13-21503004-C-A | not specified | Uncertain significance (Jan 12, 2024) | ||
13-21503071-ATC-A | not specified | Uncertain significance (May 06, 2024) | ||
13-21510028-T-C | not specified | Uncertain significance (Sep 09, 2024) | ||
13-21510055-C-T | not specified | Likely benign (Aug 12, 2021) | ||
13-21514396-T-G | not specified | Uncertain significance (Jun 10, 2024) | ||
13-21521286-T-C | not specified | Likely benign (Oct 13, 2021) | ||
13-21521307-C-T | not specified | Uncertain significance (Dec 27, 2022) | ||
13-21522633-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
13-21539371-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
13-21566820-G-A | not specified | Uncertain significance (Oct 25, 2023) | ||
13-21566847-T-A | not specified | Uncertain significance (Apr 26, 2024) | ||
13-21566882-C-A | not specified | Uncertain significance (Nov 22, 2023) | ||
13-21566898-C-T | not specified | Uncertain significance (Jun 21, 2022) | ||
13-21566916-A-G | not specified | Uncertain significance (May 09, 2022) | ||
13-21566919-T-C | not specified | Uncertain significance (Mar 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MICU2 | protein_coding | protein_coding | ENST00000382374 | 12 | 111518 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.72e-21 | 0.000576 | 124856 | 2 | 890 | 125748 | 0.00355 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.311 | 234 | 221 | 1.06 | 0.0000109 | 2844 |
Missense in Polyphen | 50 | 62.574 | 0.79906 | 846 | ||
Synonymous | -1.27 | 90 | 75.9 | 1.19 | 0.00000372 | 766 |
Loss of Function | -0.515 | 29 | 26.2 | 1.11 | 0.00000140 | 310 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00686 | 0.00676 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.000503 | 0.000489 |
Finnish | 0.000374 | 0.000370 |
European (Non-Finnish) | 0.00551 | 0.00547 |
Middle Eastern | 0.000503 | 0.000489 |
South Asian | 0.00147 | 0.00144 |
Other | 0.00447 | 0.00441 |
dbNSFP
Source:
- Function
- FUNCTION: Key regulator of mitochondrial calcium uniporter (MCU) required to limit calcium uptake by MCU when cytoplasmic calcium is low (PubMed:24503055, PubMed:24560927, PubMed:26903221). MICU1 and MICU2 form a disulfide-linked heterodimer that stimulate and inhibit MCU activity, depending on the concentration of calcium (PubMed:24560927). MICU2 acts as a gatekeeper of MCU that senses calcium level via its EF-hand domains: prevents channel opening at resting calcium, avoiding energy dissipation and cell-death triggering (PubMed:24560927). {ECO:0000269|PubMed:24503055, ECO:0000269|PubMed:24560927, ECO:0000269|PubMed:26387864, ECO:0000269|PubMed:26903221}.;
- Pathway
- Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
(Consensus)
Recessive Scores
- pRec
- 0.101
Intolerance Scores
- loftool
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.96
Haploinsufficiency Scores
- pHI
- 0.507
- hipred
- N
- hipred_score
- 0.177
- ghis
- 0.567
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Micu2
- Phenotype
- cellular phenotype; muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- mitochondrial calcium ion transmembrane transport;calcium import into the mitochondrion;mitochondrial calcium ion homeostasis;positive regulation of mitochondrial calcium ion concentration;negative regulation of mitochondrial calcium ion concentration
- Cellular component
- mitochondrion;mitochondrial inner membrane;mitochondrial intermembrane space;calcium channel complex;uniplex complex
- Molecular function
- calcium ion binding;protein binding;protein heterodimerization activity